BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Subcutaneous Injection Sites and Instructions for Safe Self Administration BPC 157: Science Backed Uses, Benefits, Dosage, and Safety A new pilot study administered BPC 157 intravenously at doses 2040 higher than what's typically used in biohacking circles 10 mg on day one and 20 mg on day two. To put